Garth Nicholas
@Garth_Nicholas1A Canadian oncologist. No pharma conflicts.
Similar User
@fred_hirsch
@BenjaminBesseMD
@EGFRSummit
@HosseinBorghaei
@peters_solange
@OncoAlert
@CharuAggarwalMD
@JSabari
@IASLC
@drgandara
@EGFRResisters
@dplanchard
@StephenVLiu
@bensolomon1
@LudaBazhenovaMD
This year for Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. 1/8
16 November: The right side of the curve For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. #lcsm 1/14
15 November: Vitamins, a note to trainees For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. #lcsm 1/14
November 14: Controversy, hierarchy For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. #lcsm 1/17
13 November: Our 1st Keynote, HR This year for Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial.#lcsm 1/17
12 November: FLAURA, intro to power For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. #lcsm 1/15
11 November: Non-inferiority, pemetrexed For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. #lcsm 1/11
10 November: CONVERT and CIs This year for Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. #lcsm 1/15
9 November: RTOG 0617 & Interim Analysis For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial.#lcsm 1/15
November 8: Consorting with MARS This year for Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial.#lcsm 1/15
7 November: IPASS and cross-over This year for Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial.#lcsm 1/13
6 Nov: Stage III surgery, primary endpoint For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial.#lcsm 1/15
5 November: ALK, KM, & a story This year for Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. #lcsm 1/15
4 Nov: Chemoradiation & patient selection For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial.#lcsm 1/11
3 Nov: ECOG, Subgroups, & Unmet Need For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial.1/12 #lcsm
2 November: Adjuvant chemo & significance This year for Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial.
1 November: Rapp and Randomization This year for Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. 1/11
United States Trends
- 1. #UFC309 314 B posts
- 2. Jon Jones 191 B posts
- 3. Jon Jones 191 B posts
- 4. Jon Jones 191 B posts
- 5. Chandler 89,6 B posts
- 6. Oliveira 73,9 B posts
- 7. Kansas 23,6 B posts
- 8. #discorddown 7.001 posts
- 9. Bo Nickal 9.228 posts
- 10. Do Bronx 11,4 B posts
- 11. ARod 2.203 posts
- 12. Pereira 11,6 B posts
- 13. Dana 264 B posts
- 14. #BYUFootball 1.423 posts
- 15. Mike Johnson 46,9 B posts
- 16. Rock Chalk 1.449 posts
- 17. Big 12 16,8 B posts
- 18. Alec Baldwin 8.772 posts
- 19. #MissUniverse 451 B posts
- 20. Keith Peterson 1.409 posts
Who to follow
-
Fred R. Hirsch
@fred_hirsch -
Benjamin Besse
@BenjaminBesseMD -
EGFR Resisters Research Summit
@EGFRSummit -
Hossein Borghaei, DO
@HosseinBorghaei -
Solange Peters
@peters_solange -
OncoAlert
@OncoAlert -
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD -
Joshua Sabari, MD
@JSabari -
IASLC
@IASLC -
David Gandara
@drgandara -
EGFR Resisters
@EGFRResisters -
d.planchard
@dplanchard -
Stephen V Liu, MD
@StephenVLiu -
Ben Solomon
@bensolomon1 -
LudaBazhenovaMD
@LudaBazhenovaMD
Something went wrong.
Something went wrong.